Day: September 18, 2020

LAS VEGAS, NV, Sept. 18, 2020 (GLOBE NEWSWIRE) — via NewMediaWire— Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a technology and numismatic company specializing in the Meso Region, including Central America and the Caribbean, announced today that the Company has recently successfully made part one of two of the final payments for $50,000 to Global Stem Cells Group on time as per the company’s LOI and filed an amended Post Closing Amendment Assignment and Assumption Agreement. “We are close to submitting our past due filings with the SEC and now, with this payment, one step closer in completing the acquisition of Global Stem Cells Group,” said David Christensen, CEO and President of the Company. “We maintain our continued optimism for the opportunities that Global Stem Cell Group brings to Stem Cell...

EL DORADO, Ark., Sept. 18, 2020 (GLOBE NEWSWIRE) — Standard Lithium Ltd., an innovative technology and lithium project development company, marks the commencement of operations at the company’s LiSTR Direct Lithium Extraction facility, with a virtual ribbon cutting event and video tour that includes a walk-through of the plant and extraction technology.Additional BackgroundLiSTR Direct Lithium Extraction Technology: LiSTR (an acronym for Lithium Stirred Tank Reactor) is an environmentally-friendly technology that selectively extracts lithium ions from tail brine that is a by-product of existing bromine production facilities run by LANXESS in south Arkansas. When compared to the conventional methods for recovering lithium from brine, the LiSTR process provides many benefits:Vastly increased recovery time – from as long as a...

NEW YORK, Sept. 18, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced that Asa Abeliovich, M.D., Ph.D., Founder and Chief Executive Officer of Prevail, will present at the virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Tuesday, September 22, 2020 at 2:30 p.m. ET.The webcast will be available in the Events and Presentations section of the Company’s website at ir.prevailtherapeutics.com. The webcast will be archived for 90 days following the presentation.About Prevail TherapeuticsPrevail is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene...

MCLEAN, Va., Sept. 18, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are multifamily mortgage-backed securities. The company expects to issue approximately $881 million in K Certificates (K-1517 Certificates), which are expected to settle on or about September 24, 2020.K-1517 PricingDetailsCo-Lead Managers and Joint Bookrunners: PNC Capital Markets LLC and J.P. Morgan Securities LLCCo-Managers: Brean Capital, LLC, Credit Suisse Securities (USA) LLC, Drexel Hamilton, LLC and Wells Fargo Securities, LLCRelated LinksThe K-1517 Preliminary Offering Circular Supplement: http://www.freddiemac.com/mbs/data/k1517oc.pdfFreddie Mac Multifamily Securitization OverviewMultifamily Securities Investor Access database of post-securitization data...

MISSISSAUGA, Ontario, Sept. 18, 2020 (GLOBE NEWSWIRE) — Smart Employee Benefits Inc. (“SEB” or the “Company”) (TSXV: SEB) is providing a corporate update.Strategic FinancingThe Company is continuing to work on completing its $20,000,000 strategic financing transaction by way of a private placement of a convertible debenture, which financing is being provided by a large strategic investor. The principal amount of the convertible debenture is convertible into common shares of the Company at $0.25 per share. The proceeds of the financing will be used to repay term indebtedness of the Company. The financing was initially announced by press release dated November 5, 2019 and most recently by press release dated August 20, 2020.The completion of the strategic financing transaction has been delayed due to challenges and delays related...

Paris, September 18th, 2020LVMH confirms that earlier today, immediately after receiving approval to proceed by the European Commission, it has submitted the proposed acquisition of Tiffany for antitrust review, as it has always stated it would do.Eight of the ten requisite antitrust clearances have already been obtained. LVMH expects to receive approval from the European Commission and Taiwan well before the November 24, 2020 Outside Date.LVMHLVMH Moët Hennessy Louis Vuitton is represented in Wines and Spirits by a portfolio of brands that includes Moët & Chandon, Dom Pérignon, Veuve Clicquot Ponsardin, Krug, Ruinart, Mercier, Château d’Yquem, Domaine du Clos des Lambrays, Château Cheval Blanc, Colgin Cellars, Hennessy, Glenmorangie, Ardbeg, Belvedere, Woodinville, Volcán de Mi Tierra, Chandon, Cloudy Bay, Terrazas de los Andes,...

Paris, le 18 septembre 2020LVMH confirme avoir reçu ce jour l’accord de la Commission Européenne pour procéder à la notification officielle du projet d’acquisition de la société Tiffany.Conformément à ce qu’elle a toujours affirmé, la société LVMH a déposé son dossier immédiatement après l’obtention de ce feu vert.Huit des dix autorisations anti-trust requises ont déjà été obtenues.   LVMH escompte recevoir les autorisations des autorités de la concurrence de l’Union Européenne et de Taiwan bien avant la date limite du 24 novembre 2020.LVMHLVMH Moët Hennessy Louis Vuitton est présent dans les Vins & Spiritueux au travers notamment des Maisons Moët & Chandon, Dom Pérignon, Veuve Clicquot Ponsardin, Krug, Ruinart, Mercier, Château d’Yquem, Domaine du Clos des Lambrays, Château Cheval Blanc, Colgin Cellars, Hennessy, Glenmorangie,...

19:15 London, 21:15 Helsinki, 18 September 2020 – Afarak Group Plc (“Afarak” or “the Company”) (LSE: AFRK, NASDAQ: AFAGR)APPROVAL OF AFARAK MOGALE (PTY) LTD BUSINESS RESCUE PLANStock Exchange ReleaseOn Wednesday 16 September creditors of Afarak Mogale (Pty) Ltd voted unanimously in favour of the adoption of the proposed business rescue plan.The adopted restructuring plan provides for the disposal of the assets of Afarak Mogale (Pty) Ltd and for the proceeds of such disposals to be utilised in settlement of the claims of creditors.The company and its advisors will now embark on a process to invite offers for the assets.Helsinki, September 18, 2020AFARAK GROUP PLCBoard of DirectorsFor additional information, please contact:Afarak Group PlcGuy Konsbruck, CEO, +356 2122 1566, guy.konsbruck@afarak.com

19:15 Lontoo, 21:15 Helsinki, 18.9.2020 – Afarak Group Oyj (”Afarak” tai ”Yhtiö) (LSE: AFRK, NASDAQ: AFAGR)AFARAK MOGALE (PTY) LTD:N SANEERAUSOHJELMAEHDOTUKSEN HYVÄKSYMINENPörssitiedoteAfarak Mogale (Pty) Ltd:n velkojat ovat 16. syyskuuta äänestäneet yksimielisesti saneerausohjelmaehdotuksen hyväksymisen puolesta.Hyväksytty saneerausohjelmaehdotus edellyttää Afarak Mogale (Pty) Ltd:n varojen myymistä ja näistä myynneistä kertyvät varat käytetään velkojien saatavien suorittamiseen.Yhtiö ja sen neuvonantajat ryhtyvät prosessiin tarjouksien hankkimiseksi varoista.Helsingissä, 18.9.2020AFARAK GROUP OYJHallitusLisätietoja:Afarak Group OyjGuy Konsbruck, toimitusjohtaja, +356 2122 1566, guy.konsbruck@afarak.comVuosikertomukset ja muut sijoittajille annettavat tiedot ovat tarkasteltavissa Yhtiön verkkosivustolla www.afarak.com.Afarak Group on...

Emerges from Chapter 11 Well-Positioned for Long-Term SuccessMoves Forward as Stronger Business With Significant Financial FlexibilityPLANO, Texas, Sept. 18, 2020 (GLOBE NEWSWIRE) — Denbury Inc. (NYSE: DEN) (“Denbury” or the “Company”) today announced that it has successfully completed its financial restructuring and emerged from Chapter 11.  Denbury’s common stock is expected to commence trading on the New York Stock Exchange under the ticker symbol DEN at market open Monday, September 21, 2020.Consistent with the previously announced Restructuring Support Agreement and the Company’s “pre-packaged” plan, Denbury has restructured its balance sheet and eliminated $2.1 billion of bond debt.  Throughout the court-supervised process, Denbury has continued to operate without interruption while fully satisfying all trade, customer, employee,...